👉👉👉Co-fellows to ➡️ Co-Professors together at MD Anderson Cancer Center ! 📚 Serious meeting of the #heme minds today with Prof Naveen Pemmaraju, MD & Prof Jason Westin, MD FACP tackling new ideas 💡 in #leusm and #lymsm | #Leadership #Excellence #CancerResearch #endcancer

DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression
nature.com/articles/s4301…
#MPNsm #leusm Nature Cancer Stephen Oh
MPN_Hub MPN Research Foundation

⭐️ It is #AML WorldAwarenessDay to raise awareness for patients, caregivers, treatment, & research! ⭐️
Know AML 🔴⚫️ The Leukemia & Lymphoma Society #KnowAML #AcuteMyeloidLeukemia #AML #leukemia #leusm

#RAS mutations in myeloid malignancies: revisiting old questions with novel insights and therapeutic perspectives
nature.com/articles/s4140…
#MDSsm #MPNsm #CMML #leusm #Resistance

Poor prognosis of #SRSF2 gene mutations in patients treated with VEN-AZA for newly diagnosed AML
doi.org/10.1016/j.leuk…
#leusm

⭐️ What wonderful work! There are no words - such a wonderful story on AML Awareness Day to have told! I’m so proud 😊 to have worked w Dr. Gail Roboz & Dr. Tsiporah Shore & the work that they do! ⭐️ Weill Cornell Leukemia Weill Cornell BMT Program @WeillCornell NewYork-Presbyterian #AMLWorldAwarenessDay #leusm

Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia ashpublications.org/blood/article-… #leusm

Thank you for highlighting the role of hematopathology and diagnostics in the care of patients with heme malignancies.
Exited to be there.
#hemepath #HOPLive24
#leusm

74 y.o. presents with WBC 7.3, Hgb 7.4, PLT 31 and 47% of these cells circulating
#leusm #hemepath WashU Heme/Onc Fellowship Hem-Onc Fellows Network
Aaron Goodman - “Papa Heme” Manni Mohyuddin

Thank you Hide, Adnan and Stephen D. Nimer, MD for allowing us to contribute to this project! Nice to see it out now Nature Communications #leusm #MPNsm Sylvester Comprehensive Cancer Center rdcu.be/dFwoy

Evaluating targeted therapies in older patients with TP53-mutated #AML tandfonline.com/doi/full/10.10… #leusm

Breakfast in Medellín with Miguel Sanz ⁦ASH⁩ we remember how hard APL was to treat before ATRA. In Mexico it is number one AML and now ATO is finally available #Leusm

great session on chronic myeloid leukemia by Drs. le Coutre, Hochhaus, and te Boekhorst at the 17th
International Hematology Expert Meeting in Prague 🤓
#CML #leusm #MPNsm
Andreas Hochhaus J.J. Kiladjian

The FDA indicated that patients and participants in clinical trials receiving CAR T-cell therapy should be monitored life-long for secondary malignancies. #mmsm #lymsm #leusm #oncology onclive.com/view/fda-requi…

Congratulations to all the authors on the acceptance of their work for the #EHA2024 🥳

I’m also looking forward to present our abstracts on the use of Gilteritinib combos for FLT3m AML and sequential alloSCT with Ven-based preconditioning. Let’s meet in #Madrid !

#leusm #bmtsm

PTCY CsA/Tacro MMF v ATG CsA/Tacro MTX as GvHD prophylaxis post allo-HSCT from sibling and unrelated donors in AML: a study on behalf of the Acute Leukemia Working Party of the The EBMT
nature.com/articles/s4140…

Mohamad Mohty The EBMT_Trainee #BMTsm #leusm

Romain Guièze, Romain Guieze, from Clermont-Ferrand, France, explains how to manage #Richter transformation at the #GCLLSG workshop in #Cologne . Excellent summary. #CLL #leusm #GCLLSG 2024

A wonderful interview with Anupama Rao (@GreatOrmondSt), taking a deep dive into pediatric hematology and the hematological predispositions to AML!🩸

🔜 Coming soon on VJHemOnc.com!

#AMLsm #Leukemia #Leusm #CaGenome #BSH2024 #HemOnc BSH - Haematology

🚨 New account alert! 🚨

We now have an Instagram account: @_allhub_

Stand by for all the exciting content we have coming soon. Click the follow button now!

#AcuteLymphoblasticLeukemia #ALLsm #Leusm #MedNews #MedEducation

EA9152 is a phase Ib/II study of venetoclax in combination with vincristine sulfate in patients with relapsed or refractory T-cell or B-cell #ALL . For more information: bit.ly/EA9152 #leukemia #leusm cc: SelinaLuger